A Real-World Study to Gain Clinical Insights Into Faricimab (FaReal Study)
Real-World, Long-Term Data Collection to Gain Clinical Insights Into Faricimab (FaReal Study)
Sponsor: Hoffmann-La Roche
This observational or N/A phase trial investigates Diabetic Macular Edema and Neovascular Age-related Macular Degeneration and is currently actively recruiting participants. Hoffmann-La Roche leads this study, which shows 16 recorded versions since 2025 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
16 versions recorded-
Mar 2026 — Present [monthly]
Recruiting
-
Feb 2026 — Mar 2026 [monthly]
Recruiting
-
Jan 2026 — Feb 2026 [monthly]
Recruiting
-
Dec 2025 — Jan 2026 [monthly]
Recruiting
-
Nov 2025 — Dec 2025 [monthly]
Recruiting
▶ Show 11 earlier versions
-
Oct 2025 — Nov 2025 [monthly]
Recruiting
-
Sep 2025 — Oct 2025 [monthly]
Recruiting
-
Aug 2025 — Sep 2025 [monthly]
Recruiting
-
Jul 2025 — Aug 2025 [monthly]
Recruiting
-
Jun 2025 — Jul 2025 [monthly]
Recruiting
-
May 2025 — Jun 2025 [monthly]
Recruiting
-
Apr 2025 — May 2025 [monthly]
Recruiting
-
Mar 2025 — Apr 2025 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Feb 2025 — Mar 2025 [monthly]
Not Yet Recruiting
-
Jan 2025 — Feb 2025 [monthly]
Not Yet Recruiting
-
Dec 2024 — Jan 2025 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Hoffmann-La Roche
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
's-Hertogenbosch, Netherlands , Ashkelon, Israel , Athens, Greece , Beer Jacob, Israel , Beersheba, Israel , Bielsk Podlaski, Poland , Coimbra, Portugal , Dublin, Ireland , Graz, Austria , Grudziądz, Poland and 37 more locations